Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001425551 | SCV001628181 | likely benign | Bloom syndrome | 2025-01-12 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV002258248 | SCV002531282 | likely benign | Hereditary cancer-predisposing syndrome | 2021-05-13 | criteria provided, single submitter | curation | |
Ambry Genetics | RCV002258248 | SCV002684503 | likely benign | Hereditary cancer-predisposing syndrome | 2019-12-31 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Natera, |
RCV001425551 | SCV002090022 | likely benign | Bloom syndrome | 2019-10-05 | no assertion criteria provided | clinical testing |